lidocaine · Medrx Usa · NDA 215029
Bondlido
Earliest generic entry, as listed
10 Nov 2028
Blocked by patent: US 8722065.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8722065 | drug product · sets the listed date | 10 Nov 2028 |
Exclusivities · 1 unexpired
| NP | new product | 24 Sep 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 215029 · 001 · RLD | system, topical | 10% | 10 Nov 2028 |